Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

STATEN ISLAND, N.Y., Oct. 28, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (ACXP) ("Acurx" or the "Company"), is a late-stage biopharmaceutical company developing a new class of antibiotics for ...

This monumental scientific achievement occurred within a context of intense international collaboration, rapid technical ...

James D. Watson, an American biologist whose 1953 discovery of the structure of DNA ushered in the age of genetics, has died ...

Manhattan: Last month, The News reported on a poll of American Jews. Sixty-one percent thought that Israel committed war ...

Ken Bain passed away on Oct. 10. I first learned this news on LinkedIn from Jim Lang, who did know and was directly mentored by Ken Bain and, like the several dozen folks who offered comments on his ...

WRN inhibitors are attracting increasing attention as a niche but fast-emerging segment within precision oncology, driven by ...

Ron Laskey is a former director of the MRC Cancer Cell Unit at the University of Cambridge, UK, and was John Gurdon’s student and colleague for more than 35 years. John Gurdon transformed biology by ...

The NBA rookie class is off to an incredible start, but there can only be one Rookie of the Year at season's end. The current ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...